tiprankstipranks
Trending News
More News >
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
US Market
Advertisement

PDS Biotechnology (PDSB) Ratios

Compare
788 Followers

PDS Biotechnology Ratios

PDSB's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, PDSB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.09 4.33 7.79 17.80 9.28
Quick Ratio
2.09 4.33 7.79 17.80 9.28
Cash Ratio
1.97 4.15 7.52 17.37 8.82
Solvency Ratio
>-0.01 -1.29 -1.24 -4.18 -3.90
Operating Cash Flow Ratio
-1.80 -2.47 -2.62 -3.32 -4.02
Short-Term Operating Cash Flow Coverage
-545.01 -8.07 0.00 0.00 0.00
Net Current Asset Value
$ 2.64B$ 25.80M$ 43.47M$ 62.85M$ 26.58M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.40 0.30 <0.01 0.02
Debt-to-Equity Ratio
<0.01 0.91 0.53 <0.01 0.02
Debt-to-Capital Ratio
<0.01 0.48 0.35 <0.01 0.02
Long-Term Debt-to-Capital Ratio
<0.01 0.43 0.34 0.00 0.00
Financial Leverage Ratio
3.67 2.27 1.75 1.06 1.14
Debt Service Coverage Ratio
-0.60 -4.62 -30.71 0.00 0.00
Interest Coverage Ratio
-1.53K -10.23 -31.65 0.00 0.00
Debt to Market Cap
2.13 0.15 0.06 0.00 0.00
Interest Debt Per Share
1.77 0.91 0.87 0.02 0.04
Net Debt to EBITDA
850.63 0.82 1.21 3.06 1.92
Profitability Margins
Gross Profit Margin
50.00%0.00%0.00%0.00%0.00%
EBIT Margin
-52032.76%0.00%0.00%0.00%0.00%
EBITDA Margin
-51988.88%0.00%0.00%0.00%0.00%
Operating Profit Margin
-13822219.40%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-15298913.07%0.00%0.00%0.00%0.00%
Net Profit Margin
-59060.35%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-59060.35%0.00%0.00%0.00%0.00%
Net Income Per EBT
0.39%96.83%97.15%78.93%100.00%
EBT Per EBIT
110.68%103.03%100.92%99.98%99.63%
Return on Assets (ROA)
-0.10%-72.31%-53.05%-25.18%-48.06%
Return on Equity (ROE)
-1.47%-164.33%-92.85%-26.77%-54.73%
Return on Capital Employed (ROCE)
-38.19%-94.07%-62.02%-33.79%-53.96%
Return on Invested Capital (ROIC)
-38.11%-83.39%-60.00%-26.56%-53.23%
Return on Tangible Assets
-0.10%-72.31%-53.05%-25.18%-48.06%
Earnings Yield
-99.82%-27.91%-10.82%-8.16%-41.43%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
<0.01 <0.01 0.04 0.19 0.12
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
<0.01 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
<0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-64.03M -44.46K -9.07K -1.94K -2.93K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
64.03M 44.46K 9.07K 1.94K 2.93K
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-513.29 -1.09 -0.90 -0.49 -0.79
Free Cash Flow Per Share
-513.29 -1.09 -0.90 -0.49 -0.79
CapEx Per Share
<0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-8.02B -8.41M 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
-8.02B -8.41M 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-309.79 -1.41 -1.10 -25.46 -21.55
Operating Cash Flow to Sales Ratio
-407.30K 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-65890.43%-21.87%-6.81%-6.02%-36.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.00 -3.58 -9.24 -12.26 -2.41
Price-to-Sales (P/S) Ratio
618.15 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
<0.01 5.89 8.58 3.28 1.32
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -4.57 -14.68 -16.61 -2.73
Price-to-Operating Cash Flow Ratio
>-0.01 -4.57 -14.68 -16.61 -2.73
Price-to-Earnings Growth (PEG) Ratio
-0.09 1.28 -0.08 0.47 0.06
Price-to-Fair Value
<0.01 5.89 8.58 3.28 1.32
Enterprise Value Multiple
849.44 -3.02 -7.86 -6.73 -0.52
Enterprise Value
-26.08B 121.12M 327.16M 142.58M 7.61M
EV to EBITDA
849.44 -3.02 -7.86 -6.73 -0.52
EV to Sales
-441.62K 0.00 0.00 0.00 0.00
EV to Free Cash Flow
1.08 -3.60 -12.73 -11.42 -0.58
EV to Operating Cash Flow
1.08 -3.60 -12.73 -11.42 -0.58
Tangible Book Value Per Share
201.70 0.84 1.54 2.47 1.62
Shareholders’ Equity Per Share
201.70 0.84 1.54 2.47 1.62
Tax and Other Ratios
Effective Tax Rate
<0.01 0.03 0.03 0.21 <0.01
Revenue Per Share
<0.01 0.00 0.00 0.00 0.00
Net Income Per Share
-0.74 -1.39 -1.43 -0.66 -0.89
Tax Burden
<0.01 0.97 0.97 0.79 1.00
Interest Burden
294.02 1.10 1.03 1.00 1.00
Research & Development to Revenue
77.73K 0.00 0.00 0.00 0.00
SG&A to Revenue
60.50K 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
49.06 0.00 0.00 0.00 0.00
Income Quality
689.63 0.78 0.63 0.74 0.89
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis